Antibody-drug conjugates refer to a highly targeted monoclonal antibody that is conjugated to a cytotoxic antitumor drug through a specific ligation fragment to combine the high selectivity of the antibody with the antitumor activity of the drug. In 2000, the first ADCs drug Mylotarg was approved by the FDA for the treatment of acute myeloid leukemia. https://www.creative-biolabs.com/adc/services.htm
Drug Discovery